Keiju Aokage

Keiju Aokage

Auto-generated profile, based on publicly available information

Keiju Aokage

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Cancer Cell
Verified
Journal Article
Closed access
SKShogo Kumagai
Shogo Kumagai
SKShohei Koyama
Shohei Koyama
KIKota Itahashi
Kota Itahashi
TTTokiyoshi Tanegashima
Tokiyoshi Tanegashima
YLYi-Tzu Lin
Yi-Tzu Lin
HNHiroyoshi Nishikawa
Hiroyoshi Nishikawa

6 March 2023 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
KAKeiju Aokage
Keiju Aokage
KSKenji Suzuki
Kenji Suzuki
HSHisashi Saji
Hisashi Saji
MWMasashi Wakabayashi
Masashi Wakabayashi
TKTomoko Kataoka
Tomoko Kataoka
MDMai Daido
Mai Daido

1 April 2018 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
KAKeiju Aokage
Keiju Aokage
TMTomohiro Miyoshi
Tomohiro Miyoshi
GIGenichiro Ishii
Genichiro Ishii
MKMasahiro Kusumoto
Masahiro Kusumoto
SNShogo Nomura
Shogo Nomura
MTMasahiro Tsuboi
Masahiro Tsuboi

26 November 2021 in Science Immunology
Verified
Journal Article
Closed access
YTYoshiko Takeuchi
Yoshiko Takeuchi
TTTokiyoshi Tanegashima
Tokiyoshi Tanegashima
ESEiichi Sato
Eiichi Sato
TITakuma Irie
Takuma Irie
ASAtsuo Sai
Atsuo Sai
HNHiroyoshi Nishikawa
Hiroyoshi Nishikawa
Activation of the WNT pathway allows highly immunogenic cancer cells to escape antitumor immunity and induce cancer progression.

2 March 2017 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
OGon behalf of the Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group
on behalf of the Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group
KAKeiju Aokage
Keiju Aokage
HSHisashi Saji
Hisashi Saji
KSKenji Suzuki
Kenji Suzuki
TMTomonori Mizutani
Tomonori Mizutani
HAHisao Asamura
Hisao Asamura

20 October 2016 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
KAKeiju Aokage
Keiju Aokage
JYJunji Yoshida
Junji Yoshida
THTomoyuki Hishida
Tomoyuki Hishida
MTMasahiro Tsuboi
Masahiro Tsuboi
HSHisashi Saji
Hisashi Saji
HAHisao Asamura
Hisao Asamura
Since ‘radical lobectomy’ was reported by Cahan in 1960, the standard surgical care for lung cancer has been lobectomy, in which units of the lobe are excised with their specific regional hilar and mediastinal lymphatics. However, pulmonary function-preserving limited resection for lung cancer has gradually become more prevalent in the late 20th century. In 1995, Ginsberg et al. conducted a randomized controlled trial in which limited resection (segmentectomy and wide-wedge resection) and lobectomy for stage I lung cancer were compared and reported that limited resection should not be applied to healthy patients with clinical stage IA lung cancer. The detection of small-sized and early-stage lung cancers has improved with advancement in diagnostic technology. Ground-glass opacity of lung nodules, as recognized on thin-slice computed tomography, has also been widely recognized as being correlated with less-invasive pathological findings of alveolar epithelial cell replacement of cancer cells. The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group conducted a cohort study of early peripheral lung cancer and investigated the validity thin-slice computed tomography criteria to diagnose non-invasive lung adenocarcinoma for the preoperative prediction of pathological non-invasive cancer. Following this observational study, the on-going JCOG0802/WJOG4607L, JCOG0804/WJOG4507L and JCOG1211 trials were initiated to confirm the validity of limited resection for stage I lung cancer patients stratified according to preoperative thin-slice computed tomography findings; these trials will clarify whether limited resection for lung cancer is not function-preserving but also only curative surgery.